Thursday, May 8, 2025

Thursday, May 8, 2025

Medicines360 News

No Results

Trending

  1. 1 GBM: Glioblastoma Multiforme Treatments Advancing as FDA Steps Up Measures Due to Rising Incidences
  2. 2 UROVANT SCIENCES: Announces U.S. FDA Approval of GEMTESA® (vibegron) 75 mg Tablets for the Treatment of Patients with Overactive Bladder (OAB)
  3. 3 TRICVALVE®: Transcatheter Bicaval Valves System granted Designation as Breakthrough Device by the U.S. Food and Drug Administration (FDA)
FDA Health News